It's probably worth to clarify that out of the 60 patients, 15 were injected with 25M and the other 15 were inject with 75M of Revascor. One of things I don't like about this study was the skew of population of class II and class III in the 150M treated and control groups
"The 150m treated patients in the phase 2 trial were mostly Class II (12 or 80%) and Class III (3 or 20%) vs Control of Class II (6 of 40%) and Class III (9 60%). This means the likelihood of HF-MACE events was inherently higher in the control vs 150m dose treated patients"
- Forums
- ASX - By Stock
- MSB
- Phase 3 DREAM HF-1 read-out
Phase 3 DREAM HF-1 read-out, page-28
-
- There are more pages in this discussion • 317 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.10 |
Change
-0.028(2.44%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.09 | $4.434M | 3.989M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 326372 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 21814 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 318473 | 1.095 |
32 | 268212 | 1.090 |
12 | 108093 | 1.085 |
20 | 809759 | 1.080 |
6 | 64525 | 1.075 |
Price($) | Vol. | No. |
---|---|---|
1.100 | 38211 | 7 |
1.105 | 101051 | 14 |
1.110 | 117993 | 11 |
1.115 | 211806 | 9 |
1.120 | 184640 | 8 |
Last trade - 12.41pm 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |